AXIOS January 2, 2024
Jason Millman

More than 500 drugs are expected to see price increases early this month, according to a new analysis.

Why it matters: Drugmakers are more likely to raise or lower drug prices around the start of a new year, but the practice may get more scrutiny as the Biden administration conducts the first-ever Medicare drug price negotiations and cracks down on companies that hike drug prices faster than inflation.

Driving the news: The tally of expected price hikes comes from Reuters’ report on an analysis from health care research firm 3 Axis Advisors.

  • Price increases in recent years have usually averaged around 5%-6%, amid public backlash over...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways

Share This Article